A category in chaosThe future of phenylephrine, a widely used OTC decongestant, is up in the air. Mucinex survey: Americans feel healthy only six months out of the yearMucinex "Power of 12" campaign shines a light on how Mucinex 12-Hour helps consumers make up for lost time. Delsym launches Bring Comfort Home campaign Delsym is creating meal kits featuring La La Anthony's family soup recipe and delivering them to 250 families throughout cold and flu season. Diabetic Tussin Maximum Strength Cough Syrup back on shelves Diabetic Tussin is formulated to provide maximum strength and multi-symptom relief for Americans with diabetes and prediabetes. Something old, something new The big five immunity ingredients are vitamins C and D, zinc, elderberry and probiotics. But other bioactives still vie for consumer acclaim. On/Go launches Sniffles Sniffles diagnoses and treats cough, the common cold and other upper respiratory conditions from home, or on the go. Walgreens releases 2023-2024 flu index Flu activity is 66% lower than this time last year, but it is 34% higher when looking at pre-pandemic seasons, such as 2018-2019. CVS to remove certain cold medicines from shelves CVS is voluntarily removing certain cough and cold medicines that contain phenylephrine from its shelves and will no longer sell them. DrKids debuts acetaminophen gummy bite for kids The latest innovation for OTC will change the way parents administer medicine to their children, the brand said. Genexa tackles cold, flu season with Kids Multi-Symptom launches An alternative to legacy brands, the new medicines do not contain artificial sweeteners, parabens or common allergens, the company said. First Previous 2 3 4 5 6 Next Last